Author:
Zhang Chufan,Chen Jianing,Song Qian,Sun Xiaoyan,Xue Meijuan,Yang Zuyi,Shang Jun
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference22 articles.
1. CTLA4 antagonists in phase I and phase II clinical trials, current status and future perspectives for cancer therapy;Szostak;Expert Opin Investig Drugs,2019
2. Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B;Zhou;J Viral Hepat,2018
3. Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect;Du;Eur Radiol,2018
4. Hantavirus-Driven PD-L1/PD-L2 Upregulation: An Imperfect Viral Immune Evasion Mechanism;Raftery;Front Immunol,2018
5. Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab;Yi;Clin Cancer Res,2017
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献